Galectin Therapeutics Inc (GALT) Insider Trading

Total insider buys:
  • $20,803,713.40
Total insider sells:
  • $17,753,147.64
Most recent insider trade:
  • Oct. 23, 2024
Most active insider trader:
  • Kevin D Freeman
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 23, 2024Director500$2.60Buy$1,300.00
Oct. 16, 2024Director5,000$2.70Buy$13,500.00
Aug. 23, 2024Director1,759$2.30Buy$4,045.70
April 30, 2024Director1,000$3.52Buy$3,520.00
April 24, 2024CEO1,000$3.39Buy$3,390.00
April 22, 2024Major Shareholder21,323$3.06Sell$65,248.38
April 22, 2024Director2,500$2.98Buy$7,450.00
Jan. 16, 2024Director500$1.79Buy$895.00
July 19, 2023Director1,598$1.79Buy$2,860.42
Feb. 21, 2023Director1,000$1.59Buy$1,590.00
Feb. 16, 2023CEO1,000$1.52Buy$1,520.00
Jan. 25, 2023Director1,300$1.11Buy$1,443.00
Nov. 17, 2022CFO4,000$1.32Buy$5,280.00
Oct. 28, 2022Director10,000$1.41Buy$14,100.00
July 28, 2022Director5,000$2.50Buy$12,500.00
May 19, 2022Director5,000$1.33Buy$6,650.00
April 18, 2022Director5,000$1.71Buy$8,550.00
April 4, 2022Director5,000$1.60Buy$8,000.00
Feb. 2, 2022Major Shareholder10,000$2.10Sell$21,000.00
Jan. 21, 2022Director1,000$2.00Buy$2,000.00
Jan. 19, 2022Director5,000$1.96Buy$9,800.00
Jan. 14, 2022Director5,000$2.02Buy$10,100.00
Jan. 11, 2022Major Shareholder10,000$2.10Sell$21,000.00
Dec. 6, 2021Director5,000$2.34Buy$11,700.00
Dec. 2, 2021Major Shareholder10,000$2.37Sell$23,700.00
Nov. 1, 2021Major Shareholder10,000$3.19Sell$31,900.00
Oct. 29, 2021Director2,000$3.17Buy$6,340.00
Oct. 21, 2021Director2,000$3.19Buy$6,380.00
Oct. 19, 2021Director3,000$3.37Buy$10,110.00
Oct. 15, 2021Major Shareholder10,000$3.37Sell$33,700.00
Oct. 4, 2021Major Shareholder10,000$3.62Sell$36,200.00
Sept. 23, 2021Director3,000$3.88Buy$11,640.00
Sept. 1, 2021Major Shareholder10,000$3.91Sell$39,100.00
Aug. 2, 2021Major Shareholder10,000$3.25Sell$32,500.00
July 9, 2021Major Shareholder10,000$3.54Sell$35,400.00
May 3, 2021Major Shareholder27,500$3.97Sell$109,175.00
April 5, 2021Director5,000$2.04Buy$10,200.00
April 1, 2021Major Shareholder10,000$2.16Sell$21,600.00
Feb. 2, 2021Major Shareholder10,000$2.04Sell$20,400.00
Jan. 11, 2021Director60,000$2.17Sell$130,200.00
Oct. 13, 2020Major Shareholder10,000$2.97Sell$29,700.00
Sept. 4, 2020Director5,000$2.57Buy$12,850.00
March 19, 2020Director6,000$1.69Buy$10,140.00
Jan. 17, 2020Major Shareholder10,000$2.97Sell$29,700.00
Nov. 15, 2019Director3,000$3.36Buy$10,080.00
Oct. 10, 2019Major Shareholder17,000$3.73Sell$63,410.00
Sept. 6, 2019Director1,290$3.71Buy$4,785.90
May 31, 2019CFO2,354$4.28Buy$10,075.12
May 31, 2019Director4,680,606$4.28Buy$20,032,993.68
April 9, 2019Director20,700$4.82Buy$99,774.00
First«1 of 3»Last
  • Insiders are both buying and selling Galectin Therapeutics Inc stock.

  • The insider traders at Galectin Therapeutics Inc are: Kevin D Freeman, Fund L.P. 10X, Peter G Traber, Jack W Callicutt, James C Czirr, Kary Eldred, Marc Rubin, Richard A Jr. Zordani, Harold H Shlevin, Joel Lewis, Richard E Uihlein, Arthur Greenberg, Theodore Daniel Zucconi, Gilbert F Amelio, Gilbert S Omenn, John F Mauldin, Steven Prelack, and Elissa J Schwartz

  • The most active insider trader at Galectin Therapeutics Inc is Kevin D Freeman with 22 trades.

  • James C Czirr has sold the most Galectin Therapeutics Inc stock with a total value of $5,546,368.61.

  • Richard E Uihlein has bought the most Galectin Therapeutics Inc stock with a total value of $40,416,566.36.

  • The most recent insider trade for Galectin Therapeutics Inc was on Oct. 23, 2024.

  • The single biggest insider buy for Galectin Therapeutics Inc was from Richard E Uihlein with a total value of $20,032,993.68 on May 31, 2019.

  • The single biggest insider sell for Galectin Therapeutics Inc was from Jack W Callicutt with a total value of $1,945,860.00 on June 20, 2018.